112 related articles for article (PubMed ID: 8392434)
1. The expression of aphidicolin-induced fragile sites in familial breast cancer patients.
Mitchell EL; Woodhouse B; Birch JM; Santibanez-Koref MF
Cancer Genet Cytogenet; 1993 Jun; 67(2):108-12. PubMed ID: 8392434
[TBL] [Abstract][Full Text] [Related]
2. The expression of common fragile sites in peripheral blood lymphocytes of breast and colorectal cancer patients with aphidicolin.
Balci A; Ekmekci A; Cetin R
Tohoku J Exp Med; 1999 Oct; 189(2):107-16. PubMed ID: 10775054
[TBL] [Abstract][Full Text] [Related]
3. Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer.
Ardisia C; Venti G; Colozza MA; Breschi C; Porfirio B; Davis S; Tonato M; Donti E
Cancer Genet Cytogenet; 1993 Jun; 67(2):113-6. PubMed ID: 8330266
[TBL] [Abstract][Full Text] [Related]
4. Expression of aphidicolin-induced fragile sites and their relationship between genetic susceptibility in breast cancer, ovarian cancer, and non-small-cell lung cancer patients.
Dhillon VS; Husain SA; Ray GN
Teratog Carcinog Mutagen; 2003; Suppl 1():35-45. PubMed ID: 12616595
[TBL] [Abstract][Full Text] [Related]
5. Expression of folate sensitive and aphidicolin induced chromosomal fragile sites in familial neuroblastoma.
Ankathil R; Kusumakumary P; Priyakumary T; Krishnan Nair M
J Exp Clin Cancer Res; 2002 Sep; 21(3):383-8. PubMed ID: 12385582
[TBL] [Abstract][Full Text] [Related]
6. Common fragile site expression and genetic predisposition to breast cancer.
Ceçener G; Egeli U; Taşdelen I; Tunca B; Duman H; Kizil A
Teratog Carcinog Mutagen; 1998; 18(6):279-91. PubMed ID: 10052563
[TBL] [Abstract][Full Text] [Related]
7. Reduced DNA repair capacity in breast cancer patients and unaffected individuals from breast cancer families.
Rao NM; Pai SA; Shinde SR; Ghosh SN
Cancer Genet Cytogenet; 1998 Apr; 102(1):65-73. PubMed ID: 9530343
[TBL] [Abstract][Full Text] [Related]
8. The expression frequency of common fragile sites and genetic predisposition to colon cancer.
Tunca B; Egeli U; Zorluoglu A; Yilmazlar T; Yerci O; Kizil A
Cancer Genet Cytogenet; 2000 Jun; 119(2):139-45. PubMed ID: 10867150
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer, Miss America, and fragile sites.
Hecht F; Hecht BK
Cancer Genet Cytogenet; 1993 Jun; 67(2):147-8. PubMed ID: 8330273
[No Abstract] [Full Text] [Related]
10. Spontaneous unusual expression of frequency of chromosome aberrations and common fragile in human lymphocytes of colorectal cancer patients induced by Aphidicolin.
Saxena AK; Agarwal CS; Kumar M; Srivastava AK; Singh G
J Exp Ther Oncol; 2007; 6(2):175-9. PubMed ID: 17407975
[TBL] [Abstract][Full Text] [Related]
11. Common fragile sites: their prevalence in subjects with constitutional and acquired chromosomal instability.
Tedeschi B; Porfirio B; Vernole P; Caporossi D; Dallapiccola B; Nicoletti B
Am J Med Genet; 1987 Jun; 27(2):471-82. PubMed ID: 3111262
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of aphidicolin and ethanol on the induction of common fragile sites.
Kuwano A; Kajii T
Hum Genet; 1987 Jan; 75(1):75-8. PubMed ID: 3100418
[TBL] [Abstract][Full Text] [Related]
13. Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures.
Craig-Holmes AP; Strong LC; Goodacre A; Pathak S
Hum Genet; 1987 Jun; 76(2):134-7. PubMed ID: 3111974
[TBL] [Abstract][Full Text] [Related]
14. Folate-sensitive and aphidicolin-inducible fragile sites are expressed in the genome of the domestic cat.
Stone DM; Stephens KE; Doles J
Cancer Genet Cytogenet; 1993 Feb; 65(2):130-4. PubMed ID: 8453598
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal fragile site expression in dogs: I. Breed specific differences.
Stone DM; Jacky PB; Hancock DD; Prieur DJ
Am J Med Genet; 1991 Aug; 40(2):214-22. PubMed ID: 1910263
[TBL] [Abstract][Full Text] [Related]
16. Population cytogenetics of aphidicolin-induced fragile sites.
Tedeschi B; Vernole P; Sanna ML; Nicoletti B
Hum Genet; 1992 Jul; 89(5):543-7. PubMed ID: 1634231
[TBL] [Abstract][Full Text] [Related]
17. Cancer chromosome breakpoints and common fragile sites induced by aphidicolin.
Hecht F; Glover TW
Cancer Genet Cytogenet; 1984 Oct; 13(2):185-8. PubMed ID: 6434179
[TBL] [Abstract][Full Text] [Related]
18. Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis.
Rao PN; Heerema NA; Palmer CG
Hum Genet; 1988 Jan; 78(1):21-6. PubMed ID: 2962925
[TBL] [Abstract][Full Text] [Related]
19. Investigation of genetic susceptibility to non-small cell lung cancer by fragile site expression.
Tunca B; Cecener G; Gebitekin C; Egeli U; Ediz B; Ercan I
Teratog Carcinog Mutagen; 2002; 22(3):205-15. PubMed ID: 11948631
[TBL] [Abstract][Full Text] [Related]
20. The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives.
Tunca B; Egeli U; Zorluoğlu A; Yilmazlar T; Yerci O; Kizil A
Cancer Lett; 2000 May; 152(2):201-9. PubMed ID: 10773413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
